Autori: Andric Zoran G
| Naslov | Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON) (Meeting Abstract) |
| Autori | Tobias Joshua ... Andric Zoran G Petrovic Z Nikolic Ivan V ... (broj koautora 17) |
| Info | ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 2, str. S886-S886 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study (Article) |
| Autori | Reck Martin ... Andric Zoran G ... (broj koautora 24) |
| Info | LUNG CANCER, (2024), vol. 196 br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Pneumologische Onkologie Tumor Treating Fields (TTFields) therapy with standard systemic therapy in metastatic non-small cell lung cancer following progression on or after platinum-based therapy: global randomized, pivotal (phase 3) LUNAR study (Meeting Abstract) |
| Autori | Weiss L ... Andric Zoran G ... (broj koautora 26) |
| Info | PNEUMOLOGIE, (2024), vol. 78 br. , Suppl. 1, str. S100-S100 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (Article) |
| Autori | Spigel David R ... Stojanovic Goran ... Andric Zoran G ... (broj koautora 17) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2024), vol. 42 br. 19, str. - |
| Projekat | Ipsen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial (Article) |
| Autori | Reck Martin ... Andric Zoran G ... (broj koautora 18) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2024), vol. 19 br. 2, str. 297-313 |
| Projekat | Healthcare business of Merck KGaA, Darmstadt, Germany; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 20) |
| Info | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, (2024), vol. 118 br. 1, str. E9-E10 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study. (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 17_SUPPL, Suppl. 17_, str. LBA9005-LBA9005 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC (Article) |
| Autori | Andric Zoran G ... Stojanovic Goran Petrovic Marina D ... (broj koautora 21) |
| Info | JTO CLINICAL AND RESEARCH REPORTS, (2023), vol. 4 br. 2, str. - |
| Projekat | Healthcare business of Merck KGaA, Darmstadt, Germany; Merck KGaA, Darmstadt, Germany; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study (Meeting Abstract) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 25) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S96-S97 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results (Meeting Abstract) |
| Autori | Liu SV ... Andric Zoran G ... (broj koautora 24) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S44-S45 |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
